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Fungal dissemination into the bloodstream is a critical step leading to invasive fungal
infections. Here, using intravital imaging, we show that Kupffer cells (KCs) in the liver have a
prominent function in the capture of circulating Cryptococcus neoformans and Candida albicans,
thereby reducing fungal dissemination to target organs. Complement C3 but not C5, and
complement receptor CRIg but not CR3, are involved in capture of C. neoformans. Inter-
nalization of C. neoformans by KCs is subsequently mediated by multiple receptors, including
CR3, CRIg, and scavenger receptors, which work synergistically along with C5aR signaling.
Following phagocytosis, the growth of C. neoformans is inhibited by KCs in an IFN-γ inde-
pendent manner. Thus, the liver filters disseminating fungi from circulation via KCs, providing
a mechanistic explanation for the enhanced risk of cryptococcosis among individuals with
liver diseases, and suggesting a therapeutic strategy to prevent fungal dissemination through
enhancing KC functions.
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Invasive fungal diseases, caused by systematic dissemination offungi, are a major threat to human health1. One of the mostimportant fungal species causing such diseases is Cryptococcus
neoformans. This organism causes fatal meningoencephalitis
predominantly in immunocompromised patients2,3, although the
infection has been reported in apparently immunocompetent
individuals4. It is estimated that there are one million cases of
cryptococcal meningoencephalitis resulting in ~600,000 deaths
every year worldwide5. While HIV infection is the main risk
factor for cryptococcal meningoencephalitis, the use of immu-
nosuppressive drugs6–8 also increases patient susceptibility to this
organism. Recently, increasing clinical studies have indicated that
patients with cirrhosis or end-stage liver diseases are also more
susceptible to brain infections with C. neoformans, establishing a
link between liver diseases and the enhanced risk for cryptococcal
meningoencephalitis6,9–12.
C. neoformans initially infects the lungs. Hematogenous dis-
semination of the fungus from the lungs is believed to be a critical
step towards meningoencephalitis13,14. Early mouse studies have
shown that brain infection occurs following fungemia15 and that
there is a direct correlation between the magnitude of fungemia
and the severity of brain infection16. In clinical settings, fungemia
is frequently detected in patients during cryptococcosis, suggest-
ing that fungemia is critical for the onset and persistence of
cryptococcal meningoencephalitis in humans17. As such, intra-
vascular clearance of disseminating C. neoformans from circula-
tion likely plays an important role in preventing and ameliorating
meningoencephalitis. However, it remains unknown whether a
mechanism exists to actively filter disseminating C. neoformans
out of the bloodstream.
To combat the invasion of C. neoformans, T cells are believed
to play a critical role18. In general, Th1 and Th17 responses are
protective while Th2 responses have been shown to be
detrimental19,20. Thus, induction of protective Th1 responses,
including enhancing IFN-γ secretion, has been used as a strategy
for vaccination design against C. neoformans21. These different T
cell responses differently shape the cytokine milieu which results
in distinct macrophage polarization. Classically activated mac-
rophages are suggested to control C. neoformans proliferation
while alternatively activated macrophages are thought to be
growth permissive22–24. The above mechanisms help explain why
patients with HIV infection or undergoing immunosuppression
are more susceptible to C. neoformans infections. However, such
mechanisms cannot directly explain the correlation between
cryptococcosis and liver diseases. Thus, it remains unknown why
liver disease is a risk factor for cryptococcal meningoencephalitis.
The liver is the biggest internal organ receiving blood supply
from both the hepatic artery and the portal vein25. It is estimated
that every minute, 30% of the body’s total volume of blood passes
through the liver25. Kupffer cells (KCs) are liver-resident mac-
rophages and constitute ~90% of total tissue macrophages in
the body26. They generally reside within the lumen of the
liver sinusoids, and adhere to the endothelial lining of blood
vessels25–27. Recent studies showed that the liver is a primary
surveillance organ for intravascular infections25, and is especially
important for filtering bacterial pathogens via KCs to maintain
blood sterility27–30. It remains unknown whether the liver plays
an important role in preventing fungal dissemination during
invasive fungal infections (including cryptococcosis) which kill
about one and a half million people every year worldwide1,31.
We formulated a hypothesis that the liver plays a prominent
role in filtering disseminating fungi out of the vasculature. In the
current study, with the use of intravital microscopy (IVM), we
examined the dynamic interactions between liver KCs and dis-
seminating fungal cells and the underlying mechanisms using
mouse models of infection with C. neoformans and Candida
albicans. The results show that liver KCs actively capture circu-
lating fungal cells, thus reducing their dissemination to target
organs. Moreover, KCs internalize captured fungal cells and
inhibit their proliferation in an IFN-γ independent manner.
Results
IVM of liver capture of circulating Cryptococcus. To determine
whether the liver filters disseminating C. neoformans, we per-
formed IVM to visualize the behavior of this organism in the liver
in real-time. Following i.v. injection via the tail vein, yeast cells
appeared in the liver within seconds. The yeast cells appeared to
move at the same speed as the blood flow and came to a sudden
stop in the liver without tethering, rolling, or crawling (Supple-
mentary Movie 1). In a series of images taken after injection,
spherical yeast cells were initially moving so fast that they were
seen as luminescent streaks; in the next image (1.2 s later), the
yeast cells were completely stopped (Fig. 1a, upper panel). Once
stopped, a portion of yeast cells were seen to be released back into
the bloodstream (Supplementary Movie 1). In another sequence of
images, an organism was seen as a luminescent streak that was
spherical in the prior frame; and in the third frame (2.5 s later), the
yeast cells had completely disappeared (Fig. 1a, lower panel). The
yeast cells were stopped in the liver sinusoids (Fig. 1b). As C.
neoformans is nearly undetectable in the bloodstream 60min after
infection (Supplementary Fig. 1), we characterized the kinetics of
yeast capture in the liver up to 50min after infection and observed
a constant increase in the number of yeast cells stopped in the liver
sinusoids over the time (Fig. 1c). As KCs are the predominant
liver-resident immune cells, we labeled liver KCs in vivo by i.v.
injection of anti-F4/80 mAb and found that most of the yeast cells
stopped in the liver were in association with KCs (Fig. 1d).
KCs catch disseminating Cryptococcus. The association of C.
neoformans with KCs shown above raised the possibility that KCs
are involved in the liver capture of circulating yeast cells. To this
end, we examined the role of KCs during the capture of C. neo-
formans by using clodronate liposomes (CLL) to deplete KCs 24 h
before infection with C. neoformans. The depletion of KCs was
confirmed by confocal microscopy (Fig. 2a) and flow cytometry
(Supplementary Fig. 2A). When comparing KC depleted mice
with control mice after i.v. infection with C. neoformans using
IVM, a dramatic decrease was observed in the number of yeast
cells captured in the liver (Fig. 2b). This was confirmed by colony
forming unit (CFU) enumeration of homogenized liver, which
showed a reduction of liver CFU by one order of magnitude after
KC depletion (Fig. 2c). Analysis of IVM videos showed that blood
clearance of circulating C. neoformans was significantly impaired
after KC depletion, resulting in a higher half-life of free yeast cells
in the bloodstream (Fig. 2d). The impaired blood clearance of C.
neoformans revealed by IVM was associated with higher blood
CFU in the absence of KCs (Fig. 2e). IVM videos showed that,
when KCs were depleted, most yeast cells were able to pass
through the sinusoids smoothly without encountering obstruc-
tions (Supplementary Movie 2). Statistical analysis of IVM videos
indicated that C. neoformans in KC depleted mice had a sig-
nificantly reduced capture possibility, indicating circulating yeast
cells were less likely to be stopped in the liver without KCs
(Fig. 2f). Moreover, the liver showed a decreased ability to steadily
hold those C. neoformans which had stopped, resulting in an
increased escape rate in KC depleted mice (Fig. 2g). Immuno-
histochemistry also confirmed the reduced liver capture of C.
neoformans in the absence of KCs in deeper sites of the liver
(Supplementary Fig. 2B). The impaired clearance was associated
with enhanced blood fungal burden, resulting in more deposition
of C. neoformans in other organs (Fig. 2h). It should be noted that
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CLL treatment also depleted spleen macrophages (Supplementary
Fig. 2C) and resulted in a reduction in spleen CFU, which indi-
cated that spleen macrophages also help capture C. neoformans.
Since the yeast cells are gradually released from the lung during
natural infections, we also infected mice intratracheally with C.
neoformans. Consistent with i.v. infection, mice depleted of KCs
exhibited significantly reduced liver capture of C. neoformans and
increased fungal burden in the brain (Fig. 2i). As CLL deplete not
only KCs but also monocytes, we treated mice with gadolinium
chloride, which was previously shown to specifically ablate KCs
or to inactivate KCs32,33. Treatment with gadolinium chloride
significantly reduced liver CFU, resulting in higher fungal bur-
dens in the blood and other tissues (Supplementary Fig. 3). To
exclude the role of circulating monocytes, we next infected
CCR2−/− and Nur77−/− mice, which lack Ly6Chi and Ly6Clow
monocytes in the bloodstream, respectively34,35. We also infected
Nur77−/− mice depleted of Ly6Chi monocytes by anti-CCR2
mAb36. We found that loss of Ly6Chi and/or Ly6Clow monocytes
did not affect the fungal burdens in the liver and other tissues 3 h
after infection with C. neoformans (Supplementary Fig. 4). Col-
lectively, these data demonstrate that KCs are critically involved
in liver capture of disseminating C. neoformans.
C3 but not C5 is required for cryptococcal capture. As C.













































Fig. 1 The dynamics of the capture of circulating C. neoformans in the liver. IVM was performed on the liver of mice (n= 5 mice) following i.v. injection of
100 × 106 GFP-labeled C. neoformans H99 via the tail vein. a A series of images taken by IVM showing the same field of view after injection. Time in minutes
and seconds after injection is shown in the images. Upper panel: a sudden stop of the yeast cells in the liver. Arrows indicate the moving yeast cells;
arrowheads indicate the same yeast cells arrested in the next frame (1.2 s later). Lower panel: release of an arrested yeast cell. Arrowhead in the left image
indicates an arrested yeast cell; arrow in the middle image indicates the same yeast cells leaving in the next frame (1.2 s later); arrowhead in the right image
indicates absence of the yeast cells 2.5 s later. b Representative IVM images showing that C. neoformans (green) was arrested in liver sinusoids (endothelial
cells were labeled with anti-PECAM-1 mAb; red) after i.v. infection with GFP-labeled C. neoformans. Upper panel: 2D image; lower panel: 3D image. c The
number of captured and free C. neoformans in a field of view at various time points after injection. At indicated time points, the number of yeast cells
captured (being stationary for >3 s) and free yeast cells traveling in the bloodstream were counted. Data are from biologically different mice (n= 5 mice,
one FOV per mouse). d PE conjugated anti-F4/80 mAb was injected into the tail vein for staining of liver KCs (red); most yeast cells (green) were
associated with KCs. Scale bars: 25 µm. Data are expressed as mean ± SEM of two independent experiments. Source data are provided as a Source Data file
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Fig. 2 KCs are critically involved in liver capture of disseminating C. neoformans. a Confocal microscopy revealed that KCs were completely depleted 24 h
after treatment with clodronate liposomes (CLL). The control mice were treated with PBS liposomes (PBS lipo). KCs (labeled by Alexa Fluor 488 anti-F4/
80 mAb): green; sinusoids (labeled by Alexa Fluor 647 anti-PECAM-1 mAb): red, pseudocolor. b Representative IVM images showing yeast cells (green,
arrows) captured in the liver of mice treated with CLL or PBS lipo 30min after i.v. injection with 100 × 106 GFP-expressing C. neoformans H99. c C.
neoformans (5 × 106) was injected into the tail vein of mice (n= 4 mice/group) treated with CLL or PBS lipo. CFU in the liver was enumerated 10min and 3
h post infection. d Vascular clearance and the half-life of circulating C. neoformans at various time points after injection of 100 × 106 yeast cells into the tail
vein of mice (n= 5 mice/group) treated with CLL or PBS lipo by analysis of IVM videos. e Blood CFU was enumerated in mice (n= 4 mice/group) treated
with CLL or PBS lipo 10min after i.v. infection of 5 × 106 C. neoformans. f The possibility of circulating C. neoformans being captured was calculated by
analysis of IVM videos from infected mice (n= 5 mice/group) treated with CLL or PBS lipo. g The possibility of trapped C. neoformans being released back
to circulation was calculated by analysis of IVM videos from infected mice (n= 5 mice/group) treated with CLL or PBS lipo. h CFU in different organs was
enumerated 3 h after i.v. injection of 5 × 106 C. neoformans into the tail vein of mice (n= 4 mice/group) treated with CLL or PBS lipo. i CFU of different
organs was enumerated 7 days after intratracheal infection with 1 × 106 C. neoformans in mice (n= 5 mice/group) treated with CLL or PBS lipo. Data are
expressed as mean ± SEM of three independent experiments. All data are from biologically distinct samples. Scale bars: 25 µm. *p < 0.05, **p < 0.01, ***p <
0.001, p values were calculated by two-way ANOVA (c, f, g) or Student’s t test (d, e, h, i). Source data are provided as a Source Data file
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we next examined the role of complement during liver capture
of C. neoformans. IVM was performed on the livers of WT and
C3−/− mice following infection with C. neoformans. Compared to
WT mice, C3−/− mice exhibited significantly fewer yeast cells in
the liver following infection (Fig. 3a, Supplementary Movie 3),
and most yeast cells were released back into the bloodstream
following a transient stop (Supplementary Movie 3). A lower liver
fungal burden confirmed the reduced liver capture of circulating
yeast cells in C3−/− mice (Fig. 3b). The reduced capture ability in
the liver resulted in impaired blood clearance and an increased
half-life of circulating yeast cells in C3−/− mice (Fig. 3c), which
was confirmed by the enhanced blood CFU in C3−/− mice post
infection (Fig. 3d). In contrast to KC depletion, analysis of IVM
videos showed that the decrease of liver CFU in C3−/− mice was
not due to the initial stop of C. neoformans. In fact, there was no
significant difference in the capture probability of C. neoformans
between WT and C3−/− mice (Fig. 3e). Instead, C3−/− mice
showed impaired ability to stably hold the stopped C. neoformans,
i.e., more stopped yeast cells were released back into circulation in
C3−/− mice compared to WT control (Fig. 3f). The reduced liver
capture of yeast cells in C3−/− mice was associated with sig-
nificantly higher fungal burden in other organs (Fig. 3g). Thus,
although C3 was not required for the initial stop of C. neofor-
mans, it is essential for C. neoformans to be retained in the liver.
To further confirm the role of complement during fungal
capture, we incubated C. neoformans with fresh serum from
either WT or C3−/− mice, and injected an equal number of WT
or C3−/− serum treated yeast cells into C3−/− mice to determine
whether opsonization could overcome the deficiency of liver
capture of the organism. Incubation with WT, but not C3−/−
mouse serum, resulted in a complete coating of C3b/iC3b on
fungal surfaces (Supplementary Fig. 5A), and this coating of C3b/
iC3b significantly rescued the liver’s capture ability in C3−/− mice
(Supplementary Fig. 5B). The complement pathway is known to
be heat liable; as a result, the recovery of capture ability in C3−/−
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Fig. 3 Complement is required for KCs to capture C. neoformans. a Representative IVM images showing yeast cells (green, arrows) captured in the liver of
WT and C3−/− mice 30min after i.v. infection with 100 × 106 GFP-expressing C. neoformans. b Liver CFU was enumerated in WT and C3−/− mice (n= 4–5
mice/group) 10 min and 3 h post i.v. infection with 5 × 106 C. neoformans H99. c Vascular clearance and the half-life of circulating C. neoformans at various
time points after injection of 100 × 106 yeast cells into tail vein of WT and C3−/− mice (n= 5 mice/group) by analysis of IVM videos. (d) Blood CFU was
enumerated in WT and C3−/− mice (n= 5 mice/group) 10min post i.v. infection of 5 × 106 C. neoformans. e The possibility of circulating C. neoformans
being captured was calculated by analysis of IVM videos from infected WT and C3−/− mice (n= 5 mice/group). f The possibility of trapped C. neoformans
being released back to circulation was calculated by analysis of IVM videos from infected WT and C3−/− mice (n= 5 mice/group). g CFU in different
organs was enumerated 3 h after injection of 5 × 106 C. neoformans into the tail vein of WT and C3−/− mice (n= 4–5 mice/group). Data are expressed as
mean ± SEM of 3 independent experiments. All data are from biologically distinct samples. Scale bars: 25 µm. *p < 0.05, **p < 0.01, ***p < 0.001. NS: not
significant. p values were calculated via two-way ANOVA (e, f) or Student’s t test (b, c, d, g). Source data are provided as a Source Data file
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(Supplementary Fig. 5C). In addition to C3b/iC3b, C5b and C6-
C9 are also deposited on microbial surfaces during opsonization.
To determine the role of these late complement activation
components during liver capture of C. neoformans, WT and
C5−/− mice were i.v. infected with C. neoformans. No significant
difference was observed in the liver CFU between infected WT
and C5−/− mice, indicating that C5b and late activation
components were not required for liver capture of C. neoformans
(Supplementary Fig. 5D). Taken together, these experiments
demonstrate that C3 but not C5 is required for KCs to capture
circulating C. neoformans.
CRIg but not CR3 is required for cryptococcal capture. Com-
plement receptor 3 (CR3 or CD11b/CD18) is the most well
characterized receptor for pathogen recognition. However, KCs
only express low levels of CD11b, compared to other phagocytes
such as neutrophils (Supplementary Fig. 5E). To determine
whether the low expression of CR3 contributes to liver capture of
C. neoformans, liver fungal burdens of WT and CD11b−/− mice
were compared following i.v. infection. The result indicated that
CR3 plays a negligible role in liver capture of C. neoformans
(Supplementary Fig. 5F).
In addition to CR3, a unique complement receptor, CRIg, was
recently identified as being expressed on KCs39. Using immuno-
histochemistry and flow cytometry, we confirmed CRIg expres-
sion on KCs (Fig. 4a, b) but not spleen macrophages
(Supplementary Fig. 5G). Since the gene encoding CRIg is
located on the X chromosome, we also checked expression levels
for male and female mice using flow cytometry. We did not detect
significant differences in CRIg expression between male and
female mice (Fig. 4b), which indicated that this gene does not
escape X-inactivation. To determine the role of CRIg in liver
capture of C. neoformans, WT and CRIg−/− mice were i.v.
infected with C. neoformans. Compared to infected WT mice,
infected CRIg−/− mice displayed a significantly lower fungal
burden in the liver (Fig. 4c). This was associated with enhanced
blood CFU (Fig. 4d), which led to higher fungal burdens in other
organs (Fig. 4e). IVM revealed dramatically reduced capture of C.
neoformans in the livers of CRIg−/− mice compared to WT mice
(Fig. 4f). Analysis of IVM videos showed impaired blood
clearance and an enhanced half-life of circulating yeast cells in
CRIg−/− mice (Fig. 4g). In consistence with C3−/− mice, there
was no significant difference in capture probability of C.
neoformans between CRIg−/− and WT mice (Fig. 4h). However,
CRIg−/− mice showed a significantly higher escape probability
(Fig. 4i), implying that more yeast cells were released back into
the bloodstream after a transient stop. Together, these results
demonstrate that CRIg but not CR3 is critically involved in KC
mediated capture of circulating yeast cells.
Uptake of Cryptococcus by KCs involves multiple receptors.
KCs are professional phagocytes. Following capture of C. neo-
formans, most of the yeast cells were internalized by KCs as
shown by IVM (Fig. 5a; Supplementary Movie 4). To reveal the
mechanisms underlying phagocytosis of C. neoformans, we
developed a system, based on published literature, to distinguish
yeast cells outside KCs from those inside KCs in mice infected
with GFP-expressing C. neoformans by i.v. injection of the fungal
specific dye Uvitex 2B40,41. GFP-expressing yeasts outside pha-
gocytes can be stained by Uvitex 2B while those phagocytized
cannot (Supplementary Fig. 6A). As shown in Fig. 5b and Sup-
plementary Fig. 6B, C. neoformans captured in the liver of WT
mice was rapidly engulfed, with more than 90% of the yeast cells
located intracellularly in as short as 15 min after infection. By
contrast, only half of the yeast cells were engulfed in C3−/− mice
15 min after infection. However, most of the yeast cells were
eventually phagocytized in C3−/− mice at a later time point
(Fig. 5b). Nevertheless, C3−/− mice showed significantly reduced
phagocytosis rates at all-time points examined (Fig. 5b), indi-
cating a role of C3 in KC phagocytosis of C. neoformans. Inter-
estingly, C5−/− mice also exhibited delayed and impaired
phagocytosis of C. neoformans in general compared to WT mice
(Fig. 5b). Thus, phagocytosis of captured C. neoformans by liver
KCs is mediated by C3, with involvement of C5.
To identify the receptors involved in phagocytosis of C.
neoformans on KCs, we compared the phagocytosis efficiency of
WT mice with CD11b−/− (CR3 deficient), CRIg−/− mice, and
double deficient mice (CRIg−/− mice treated with CD11b
blocking mAb). Interestingly, single deficiency of either CD11b
or CRIg did not affect phagocytosis efficiency. However, the
deficiency of both CRIg and CD11b significantly reduced the
phagocytosis rate (Fig. 5e), indicating functional redundancy
between CR3 and CRIg on KCs. In addition to CR3 and CRIg,
KCs express high levels of C5aR as revealed by flow cytometry
(Fig. 5c); a blockade for C5aR using blocking mAb significantly
reduced the phagocytosis rate in WT mice (Fig. 5d), indicating a
critical involvement of C5aR signaling. Given that some of the
yeast cells could eventually be phagocytized in the liver of C3−/−
mice (Fig. 5b), it is conceivable that other receptors also
contribute to phagocytosis independent of complement. Accord-
ingly, we found that inhibition of scavenger receptors by Poly I
significantly inhibited phagocytosis especially in C3−/− mice
which do not have complement-mediated phagocytosis (Fig. 5f,
g). Collectively, these results suggest that phagocytosis of C.
neoformans in the liver under shear stress is mediated by both
complement-dependent and -independent pathways involving
multiple receptors including CR3, CRIg, and scavenger receptors,
and that the process can be significantly enhanced by the
presence of C5aR signaling.
KCs inhibit cryptococcal growth after phagocytosis. The ability
of C. neoformans to grow within macrophages prompted us to
study the fate of this organism following phagocytosis by KCs.
Interestingly, the vast majority of yeast cells remained as single-
cell colonies in the liver 3 days after infection, whereas more than
90% of yeast cells trapped in other organs were proliferating and
forming fungal clusters (Fig. 6a, b). As we have shown above,
most of the yeast cells captured in the liver were engulfed by KCs,
this finding raised the possibility that KCs inhibit C. neoformans
growth in the liver. To this end, we depleted KCs using CLL
before infection and found that C. neoformans proliferated in the
liver as it did in other organs (Fig. 6c). In livers depleted of KCs,
the majority of yeast cells started to grow and formed clusters,
which is in contrast to the normal liver where fungal growth was
suppressed (Fig. 6d).
IFN-γ can classically activate macrophages, resulting in killing
or growth inhibition of C. neoformans within macrophages24.
Invariant natural killer T cells (iNKT cells) are abundant in the
liver and are known to produce IFN-γ following activation.
Interestingly, IVM on the liver of CXCR6gfp/+ mice revealed that
clusters of iNKT cells were formed in the liver of mice following
i.v. infection with C. neoformans; but this was not seen in the liver
of naïve mice (Fig. 6e, f). Clusters of iNKT cells have also been
seen in the liver following infection with the bacterial pathogen
Borrelia burgdorferi, which is linked to iNKT cell activation and
IFN-γ secretion42. In consistence with the published study42, we
detected IFN-γ production in the liver following i.v. infection
with C. neoformans (Fig. 6g). To determine whether IFN-γ has
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the potential to activate KCs, we confirmed that KCs express IFN-
γR via flow cytometry (Fig. 6h). Surprisingly, IFN-γR−/− mice
did not show any impairment in inhibition of fungal growth in
the liver as determined by enumerating the yeast cells per colony
(Fig. 6i). This was confirmed by the evidence that there was no
significant difference in the liver CFU between infected WT and
IFN-γR−/− mice (Fig. 6j). Thus, KCs inhibit C. neoformans
growth following phagocytosis, in a manner which is independent
of IFN-γR signaling.
KCs catch circulating Candida and inhibit hyphal growth.
Having demonstrated the critical role of the liver in filtering
disseminating C. neoformans via KCs, we next examined whether
liver KCs also capture circulating C. albicans, another important
fungal pathogen responsible for invasive candidiasis43. Depletion
of KCs using CLL dramatically reduced the liver fungal burden
(Fig. 7a), leading to more deposition of yeast cells in the target
organ, the kidney, following i.v. infection with C. albicans
(Fig. 7b). Importantly, almost all yeast cells developed hyphae in
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the liver depleted of KCs but not in the normal liver (Fig. 7c, d),
implying that the yeast cells were engulfed by KCs and that KCs
inhibited hyphal growth. In contrast, treatment with CLL did not
affect the hyphal growth in the kidney of mice infected with C.
albicans (Fig. 7e, f). Thus, in addition to C. neoformans, KCs also
mediate liver capture of circulating C. albicans and inhibit its
hyphal growth.
Discussion
Approximately 1.2 billion people suffer from fungal diseases
worldwide43. The most serious manifestation occurs when
pathogenic fungi disseminate from the initial infection sites into
the blood, where they are able to cause invasive fungal infections,
accounting annually for one and a half million deaths
worldwide1,31. Although it is known that blood dissemination is a
critical step for the onset of invasive fungal diseases, the
mechanisms to prevent dissemination have been poorly under-
stood. This is mainly because fungal dissemination via the host
circulatory system is a dynamic process, and investigation of
mechanisms to prevent dissemination requires dynamic obser-
vation approaches. In this study, with the use of IVM, we
examined the dynamic interactions of KCs with circulating C.
neoformans under shear forces and flow conditions in vivo,
demonstrating that the liver plays a prominent role in filtering
disseminating C. neoformans out of vasculature via KCs in both
i.v. and pulmonary infection models, leading to less fungal
deposition in the target organ. Importantly, liver KCs also catch
C. albicans circulating in the bloodstream, reducing kidney
infection. Thus, our studies reveal that a mechanism exists in the
liver of hosts to actively filter disseminating fungal pathogens out
of circulation during invasive fungal infections.
C. neoformans is an opportunistic fungal pathogen which
causes meningoencephalitis primarily in immunocompromised
individuals44,45. Alveolar macrophages are believed to play a
vital role in the initial host response after C. neoformans infec-
tion46. HIV infection and immunosuppressive therapies are
major risk factors for the development of brain infection,
because individuals infected with HIV or treated with immu-
nosuppressive drugs are unable to contain C. neoformans in the
lung and the organism disseminates to the brain via the
bloodstream13,14. Recently, accumulating clinical evidence has
established a strong correlation between liver diseases including
cirrhosis and cryptococcal meningoencephalitis, suggesting that
liver disease is another independent risk factor for cryptococcal
meningoencephalitis6,10,47. However, it remains completely
unknown as to how liver diseases link to cryptococcal menin-
goencephalitis. One major contribution of the current study to
the field is that the identification of the critical role of the liver in
filtering disseminating C. neoformans via KCs provides a
mechanistic explanation for the enhanced susceptibility of
individuals with liver diseases to cryptococcal infection. In line
with this explanation, liver cirrhosis patients show an impaired
ability to clear blood bacteria with prolonged bacteremia per-
sistence48 and have a higher risk of dying from bacterial infec-
tions based on existing medical data on infectious risks and
related preventive and treatment data for cirrhotic patients49.
In the past decade, extensive studies have been performed
focusing on the capture of bacterial pathogens by KCs in the
liver27,29,39,42,50–53. Nevertheless, the underlying mechanisms
have not been elucidated until recently. Broadley et al. recently
reported that a dual-track mechanism consisting of parallel fast
and slow pathways exists for KCs to capture a broad panel of
Gram-positive and Gram-negative bacteria29. The fast clearance
of platelet-free bacteria is mediated by scavenger receptors while
platelet binding shifts bacteria from fast to a slow clearance
pathway mediated by the complement receptor CRIg29. In the
absence of complement, circulating bacteria are captured by KCs
though scavenger receptors but not CRIg29. This explains why
there was no difference in liver capture of Staphylococcus aureus
between C3−/− mice and C3−/−CRIg−/− mice, despite the dif-
ference in liver capture of S. aureus between CRIg−/− mice and
wild-type mice as reported earlier by Helmy et al.39. Indeed, CRIg
expressed on KCs functions as a pattern recognition receptor to
directly bind circulating bacteria through lipoteichoic acid
recognition27. Although CRIg was involved in slow clearance of
bacteria as reported recently by Broadley et al.29, it could not be
ruled out that CRIg bound bacterial lipoteichoic acid rather than
C3b/iC3b in this experimental setting29. Therefore, although
CRIg was originally identified as a macrophage complement
receptor, whether CRIg binds bloodborne pathogens through
interacting with complement in vivo under flow conditions has
not been fully addressed.
Interestingly, although opsonization by complement facilitates
bacterial binding to macrophages under static conditions54,55,
complement is dispensable for KCs to capture circulating bacteria
such as Listeria monocytogenes and S. aureus under flow
conditions27,29,52. In the current study, IVM revealed that C.
neoformans was suddenly stopped in the liver sinusoids in the
same manner as it was seen to be mechanically trapped in the
capillary bed of the brain43,56. Accordingly, deficiency of C3 or
CRIg did not affect the initial stop of C. neoformans at all.
However, C3 and CRIg are required for the yeast cells to be
retained in the sinusoids, indicating that both C3 and CRIg are
involved in KC-mediated capture of C. neoformans. Among all
identified complement receptors, KCs only express CR3 and
CRIg39. Given that deficiency of CR3 did not affect the capture of
C. neoformans, it is highly likely that CRIg is involved in C3-
dependent KC-mediated capture of disseminating C. neoformans,
unless C3 acts via a currently unidentified receptor on KCs. In
Fig. 4 CRIg is the receptor on KCs mediating the capture of C. neoformans. a Immunofluorescence staining showing the expression of CRIg (green) on KCs
(red) of WT mice (upper panel) but not CRIg−/− mice (lower panel). The nuclei were stained with DAPI (blue). b The expression of CRIg on KCs of WT
(male and female) but not CRIg−/− mice (gated on CD45+F4/80+CD11bint population). c Liver CFU was enumerated in WT and CRIg−/− mice (n= 4
mice/group) 10 min and 3 h after i.v. infection with 5 × 106 C. neoformans. d Blood CFU was enumerated in WT and CRIg−/− mice (n= 4 mice/group) 10
min post i.v. infection of 5 × 106 C. neoformans. e CFU of different organs was enumerated in WT and CRIg−/− mice (n= 4 mice/group) 3 h after i.v.
infection of 5 × 106 C. neoformans. f Representative IVM images showing yeast cells (green) captured in the liver of WT and CRIg−/− mice (n= 5 mice/
group) 30min after i.v. infection with 100 × 106 GFP-labeled C. neoformans. g Vascular clearance and half-life of circulating C. neoformans at various time
points after injection of 100 × 106 yeast cells into tail vein of WT and CRIg−/− mice (n= 5 mice/group) by analysis of IVM videos. h The possibility of
circulating C. neoformans being captured was calculated by analysis of IVM videos from infected WT and CRIg−/− mice (n= 5 mice/group). i The
possibility of trapped C. neoformans being released back to circulation was calculated by analysis of IVM videos from infected WT and CRIg−/− mice (n= 5
mice/group). Scale bars: 25 µm. Data are expressed as mean ± SEM of two independent experiments. All data are from biologically distinct samples. *p <
0.05, **p < 0.01, ***p < 0.001. p values were calculated via two-way ANOVA (c, h, i) or Student’s t test (d, e, g). Source data are provided as a Source
Data file
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addition, by contrast to bacteria29, we found that platelets were
not involved in the KC-mediated capture of C. neoformans
(Supplementary Fig. 7). Thus, although KCs mediate both fungal
and bacterial capture, the underlying mechanisms are different,
i.e., capture of fungal pathogens such as C. neoformans is both
CRIg and C3 dependent while capture of bacterial pathogens such
as S. aureus and L. monocytogenes is CRIg dependent but C3
independent. The ability to activate complement and the size
differences among the microorganisms may account for the dif-
ference. C. neoformans can efficiently activate complement,
leading to a rapid and heavy deposition of C3b/iC3b on the
surface of yeast cells38. By contrast, bacteria such as S. aureus
develop an evasion strategy to inhibit C3b deposition onto their
surfaces57,58. In addition, C. neoformans is much bigger than
bacteria, resulting in a mechanical trapping of the yeast cells in
the sinusoids. The initial transient stop provides a static condition
which may allow for interactions between CRIg and the C3b/iC3b
deposited on the yeast cells to occur39.
Notably, C. neoformans was rapidly engulfed by KCs following










































































































































Fig. 5 C. neoformans is rapidly engulfed by KCs through multiple receptors. a IVM on the liver showing phagocytosis of C. neoformans (green) by KCs (red) 1 h
post i.v. infection of 100 × 106 GFP-labeled C. neoformans. Upper panel: 2D image; lower panel: 3D reconstructive image of the upper panel. b The percentage of
C. neoformans outside KCs in the liver was determined by in vivo staining of fungi by Uvitex 2B in WT, C3−/−, and C5−/− mice (n= 5 mice/group) at various
time points following i.v. infection with 20 × 106 GFP-expressing C. neoformans H99. c The expression of C5aR on KCs (gated on CD45+F4/80+CD11bint
population) was analyzed by flow cytometry. d The role of C5aR signaling on phagocytosis of C. neoformans by KCs in the liver was determined by in vivo
staining of fungi by Uvitex 2B in mice (n= 5 mice/group) treated with anti-C5aR blocking antibody or control antibody 10min after i.v. infection with 20 × 106 C.
neoformans. e The percentage of C. neoformans outside KCs was determined in the liver of WT, CD11b−/− (CR3 deficient), CRIg−/− mice, and CRIg−/− mice
treated with anti-CD11b blocking antibody (n= 5 mice/group) 10min post i.v. infection of 20 × 106 GFP-expressing C. neoformans. f, g To block scavenger
receptors, WT and C3−/− mice (n= 5 mice/group) were i.v. injected with 400 µg Poly(I) or 400 µg Poly(C) as control, followed by i.v. infection of 20 × 106
GFP-expressing C. neoformans 2min later. The percentage of C. neoformans outside KCs was determined in the liver of WT mice (f) and C3−/− mice (g) 15 and
90min after infection. Scale bar: 25 µm. Data are expressed as mean ± SEM of two independent experiments. All data are from biologically distinct samples.
*p < 0.05, ***p < 0.001. p values were calculated via two-way ANOVA (b, f, g), one-way ANOVA followed by Tukey’s post hoc test (e) or Student’s t test (d).
Source data are provided as a Source Data file
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12381-5 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:4566 | https://doi.org/10.1038/s41467-019-12381-5 | www.nature.com/naturecommunications 9
to KCs without being phagocytized59. We demonstrated that C3,
together with CR3 and CRIg, is involved in KC-mediated pha-
gocytosis of C. neoformans, a process facilitated by C5aR signal-
ing. It remains to be elucidated as to how C5aR signaling
enhances phagocytosis. Interestingly, scavenger receptors are also
involved in KC-mediated phagocytosis of C. neoformans, which is
consistent with earlier studies showing the uptake of bacteria by
KCs through scavenger receptors50. It is worth to note that
complement-mediated phagocytosis of C. neoformans nearly
overshadowed the effect of scavenger receptors and that the effect
of these receptors become pronounced only in the absence of
complement.
In sharp contrast to alveolar macrophages, which promote the
intracellular growth of C. neoformans46, we reveal that KCs
inhibit the growth of ingested yeast cells. Thus, KCs are not only
critical to filter C. neoformans out of vasculature, but also limit
fungal growth, reducing the risk of secondary dissemination of
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Fig. 6 KCs suppress the growth of C. neoformans in an IFN-γ-independent manner. a Representative images showing the growth of C. neoformans in
different organs 3 days after i.v. infection with 20 × 106 GFP-labeled C. neoformans. b The number of C. neoformans per colony at various time points
after infection. c Mice were treated with CLL or PBS lipo and 24 h later i.v. infected with 20 × 106 GFP-labeled C. neoformans. The yeast cells at each
colony were counted in the liver 3 days post infection. Left panel: representative images showing the growth of C. neoformans; right panel: the number
of C. neoformans per colony. d The percentage of C. neoformans growing in the liver of mice treated with CLL or PBS lipo following i.v. infection of 20 ×
106 GFP-labeled C. neoformans. e Representative IVM images showing clusters of iNKT cells in the liver of CXCR6gfp/+ mice 0, 2, and 5 days post i.v.
infection with 20 × 106 C. neoformans. f The size of iNKT cell clusters in the liver of CXCR6gfp/+ mice 0, 2, and 5 days post i.v. infection with 20 × 106 C.
neoformans. g IFN-γ amounts in the liver homogenates of mice i.v. infected with 20 × 106 C. neoformans. h The expression of IFN-γR on KCs of WT but
not IFN-γR−/− mice (gated CD45+F4/80+CD11bint population). i WT and IFN-γR−/− mice were i.v. infected with 20 × 106 GFP-labeled C. neoformans.
The fungal growth was assessed by counting the yeast cells at each colony in the liver 2 and 5 days after infection. j The fungal burdens in different
organs of WT and IFN-γR−/− mice 5 days following i.v. infection with 1 × 106 C. neoformans. Data from different field of views of mice (n= 5 mice/
group) were pooled together (b, c, f, i). Data are from biologically distinct samples (n= 5 mice/group, d, g, j). Scale bars: 25 µm. Data are expressed as
mean ± SEM of two independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. NS: not significant. p values were calculated by one-way ANOVA
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PBS lipo kidney 5 h CLL kidney 5 h
CLL liver 5 h
Fig. 7 Liver KCs catch circulating C. albicans and inhibit its hyphal growth. a, b Mice (n= 5 mice/group) were treated with CLL or PBS lipo as control to
deplete KCs and 24 h later i.v. infected with 5 × 106 C. albicans. CFU was enumerated 3 h post infection in the liver (a) and kidney (b). c, d Mice (n= 5
mice/group) were treated with CLL or PBS lipo as control to deplete KCs and 24 h later i.v. infected with 20 × 106 Uvitex 2B-labeled C. albicans. IVM was
performed on the liver 5 h after infection to image the fungi. Representative images showing C. albicans in the liver (c). The percentage of C. albican
with hyphae was determined by IVM (d). e, f Mice (n= 5 mice/group) were treated with CLL or PBS lipo as control to deplete KCs and 24 h later i.v.
infected with 20 × 106 Uvitex 2B-labeled C. albicans. Kidney was excised 5 h post infection and immediately visualized under microscope. Representative
images showing C. albicans in the kidney (e); The percentage of C. albicans with hyphae was determined (f). Scale bars: 25 µm. Data are expressed as
mean ± SEM of two independent experiments. All data are from biologically distinct samples. *p < 0.05, ***p < 0.001. p values were calculated by Student’s
t test (a, b, d, f). Source data are provided as a Source Data file
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preventing fungal dissemination on multiple levels. Interestingly,
phagocytosis of C. neoformans by KCs leads to clustering of
iNKT cells, which has been seen in the liver following phagocy-
tosis of B. burgdorferi by KCs and is indicative of iNKT cell
activation42. IFN-γ detected in the liver following phagocytosis of
C. neoformans was likely secreted by the activated iNKT cells.
Surprisingly, absence of IFN-γ-signaling did not affect the growth
inhibition of C. neoformans within KCs, demonstrating KCs
inhibit fungal growth in an IFN-γ-independent manner. This
result is of interest because it implies that enhancing liver mac-
rophage recruitment can be a potential strategy to prevent dis-
semination of C. neoformans, even for those who are infected
with HIV and have an impaired secretion of IFN-γ due to loss of
CD4+ T cells.
In conclusion, with the use of IVM we reveal that a mechanism
exists to actively filter disseminating fungal pathogens via liver
KCs, providing a mechanistic explanation for the higher risk of
cryptococcal meningoencephalitis to those suffering from liver
diseases. We further demonstrate that C3 is critically involved in
the capture of yeast cells through CRIg signaling, a mechanism
that has not been reported in KC-mediated capture of bacterial
pathogens. Following capture, fungal pathogens are rapidly
engulfed by KCs via multiple receptors, working synergistically,
which is driven by C5aR signaling. Interestingly, KCs inhibit the
growth of ingested yeast cells in an IFN-γ independent manner.
Thus, KCs play a prominent role in preventing fungal dis-
semination via multiple mechanisms and enhancing KC func-
tions may ameliorate invasive fungal infections in clinical settings.
Methods
Animals. Wild type C57BL/6 mice were purchased from the National Cancer
Institute (NCI). All knockout mice including C3−/− (Catalog No. 003641), C5−/−
(Catalog No. 000461), CD11b−/− (Catalog No. 003991), CRIg−/− (Catalog No.
024408), IFNγR−/− (Catalog No. 003288), and CXCR6gfp/gfp (Catalog No. 005693)
mice were purchased from The Jackson Laboratory and bred in the animal facilities
of University of Maryland, College Park. Mice were always maintained in specific
pathogen free individually ventilated cages. For all experiments, 8- to 12- week old
mice with body weight ranging from 18 to 22 g were used. The authors affirm that
the study complied with all relevant ethical regulations for animal testing and
research. The animal study protocol was approved by the Institutional Animal Care
and Use Committee (IACUC) of the University of Maryland, College Park.
Fungal strains and culture. Encapsulated C. neoformans H99 strain (serotype A)
was used in this study. To visualize the fungi under IVM, GFP-expressing C.
neoformans H99, a gift of Dr. Robin May (University of Birmingham), was used in
the experiments. For experiments related to Candida albicans, the wild-type strain
(SC5314) was used. The fungi were cultured to exponential phase at 32 °C with
gentle rotation in an orbital shaker (180 rpm) in Sabouraud dextrose broth (BD)
and harvested by centrifugation at 400 × g for 5 min. After washing with PBS twice,
the fungal concentration was determined using a hemocytometer.
Infections and treatments. In most experiments, mice were infected with 5 × 106,
20 × 106, or 100 × 106 C. neoformans or C. albicans via the tail vein. In some
experiments, mice were intratracheally infected with 1 × 106 C. neoformans in 50 µl
sterile PBS via a midline neck incision under anesthesia. Depletion of KCs was
achieved by i.v. treatment with 200 µl of CLL 24 h before infection. The depletion
of KCs can be maintained for as long as 1 week after a single treatment. Platelets
were depleted by treating mice with 100 µg of anti-CD41 mAb (Catalog No.
133910, Biolegend). For blocking scavenger receptors, mice were i.v. injected with
400 μg of polyinosinic acid (poly(I)) or polycytidylic acid (poly(C)) as control
2 min prior to infection29.
Quantification of fungal burdens in the blood and organs. For fungal burden
determination, mice were infected with 5 × 106 C. neoformans H99 or C. albicans
and euthanized at various time points after infection. To determine fungal burden
in the blood, mice were anesthetized by a ketamine/xylazine mixture; blood was
taken by cardio-puncture using a 1 ml syringe containing 50 μl of heparin (100 U/
ml). To determine fungal burdens in the tissues, the lung, liver, brain, kidney, and
spleen were collected into 15 ml tubes each containing 2 ml ice cold PBS. To avoid
contamination of tissues by circulating fungi, perfusion was performed using 20 ml
PBS from the left ventricle after cutting open the inferior vena cava. The organs
were homogenized with a hand-held tissue homogenizer (Omni international,
USA). After serial dilution and plating on Sabouraud dextrose agar plate, CFUs
were enumerated after 36 h of growth at 32 °C.
Intravital microscopy (IVM). Mice were anaesthetized with a mixture of ketamine
(200 mg/kg) and xylazine (10 mg/kg). After anesthesia, cannulation of the tail vein
was performed for injection of additional mixture of ketamine and xylazine to
maintain anesthesia and for injection of yeast cells or other reagents. A midline
laparotomy was performed by making a midline incision followed by a lateral
incision along the costal margin to the midaxillary line. A high temperature cautery
was used to prevent blood vessel from bleeding when cutting. The xiphoid process
was lifted using a suture attached to it, and the connective tissues between the liver
and the diaphragm was cut. The mice were placed in right lateral position. After
cutting the connective tissues between the liver and stomach, the liver was exter-
nalized onto a customized acrylic imaging stage and covered with a cover slip. A
heating lamp was used to maintain the body temperature of the mice throughout
the imaging. The liver was continuously moistened with a saline-soaked sponge to
prevent tissue dehydration and to help restrict movements. The heart rate was
maintained constant during the period of imaging (Supplementary Fig. 8). The
perfusion of the blood to the liver was monitored by visualization of the blood cell
movement under the intravital microscope.
Video capture and analysis. The Zeiss Axio Examiner Z1 system (Zeiss,
Germany) was used for the intravital imaging. After the preparations and settings,
mice were infected with 100 × 106 GFP-expressing C. neoformans through the
catheter in the tail vein and video recording began immediately. In some experi-
ments, mice were i.v. injected with 2 µg of PE conjugated anti-F4/80 (Catalog No.
123110, Biolegend) or anti-PECAM-1 (Catalog No. 102508, Biolegend) antibodies
to label liver KCs or sinusoids 5 min prior to injection of the yeast cells. A 20×
objective lens was used throughout the experiment and time-lapse videos were
recorded at the speed of 1 frame per second for later playback and analysis. Due to
limited tissue penetration of visible light, a superficial field of view (FOV) of up to
40 µm was focused. One FOV was recorded per mouse. For statistical analysis, the
following events were counted for each video: (1) the total number of yeast cells
that appeared in the (FOV, 0.5 mm × 0.5 mm) within a time interval; (2) the
number of yeast cells that were captured in the FOV within a time interval; and (3)
the number of yeast cells which escaped after capture. We define capture as a
fungus coming to a full stop and remaining stationary for at least 3 s. Those yeast
cells staying in a locus for more than 3 s and being released into circulation were
deemed as an escape. Next, we calculated the probability of fungi getting captured
by comparing the number of captured yeast cells with total appearing yeast cells.
The probability of escape was calculated by comparing the number of escaped yeast
cells with total captured yeast cells. Fungal clearance in the blood (% blood
clearance) was calculated as the number of free fungi that entered the FOV within a
one-minute window divided by the number of free fungi that entered the FOV
within the first minute (the first minute is defined as 0% clearance). The half-life of
circulating fungi was calculated as the time needed to clear 50% of circulating fungi
in the blood.
Immunohistochemistry and confocal microscopy. The tissues were removed and
frozen in OCT compound. Frozen tissue blocks were cut on a cryostat microtome
with a thickness set to 7 μm/section; and sections were placed on coated glass slides.
Tissue sections were fixed in ice cold acetone for 10 min. After fixation, the samples
were blocked by incubation with 5% goat serum for 30 min, followed by incubation
with the primary antibody at 4 °C overnight. After three washes with PBS con-
taining 0.05% Tween 20, sections were incubated for 30 min with the fluorescence
conjugated second antibodies. After washing, the tissues were stained with DAPI to
show the nuclei and persevered in mounting buffer. The tissue slides were exam-
ined under the Zeiss LSM 510 system. To confirm depletion of KCs, mice were i.v.
injected with 2 µg Alex Fluor 488 anti-F4/80 mAb (Catalog No. MF48020, Invi-
trogen) and 2 µg Alex Fluor 647 anti-PECAM1 mAb (Catalog No. 102516, Bio-
legend) in 200 µl PBS to label KCs and blood vessels, respectively. Ten minutes
later, mice were euthanized and perfused with 20 ml cold PBS after cutting the vena
cava open until the liver became pale. Then the whole liver was excised carefully
and placed on a 35-mm glass-bottom dish (thickness no. 1.5; MatTek, USA)
containing 1 ml RPMI 1640 with 10% FBS. The whole-mount liver was examined
under the Zeiss LSM 510 system using 63X oil immersion lens.
Phagocytosis assay. Mice were i.v. infected with 20 × 106 GFP-expressing C.
neoformans. To label extracellular yeast cells, the infected mice were i.v. injected
with 100 μl of Uvitex 2B (1% w/v in PBS, Polysciences Inc.) at various time points
after infection. The staining of extracellular C. neoformans by Uvitex 2B occurred
almost immediately after administration of Uvitex 2B. Mice were euthanized 2 min
after treatment of Uvitex 2B and perfusion was performed; the liver was excised
and examined under a microscope to count the number of yeast cells inside or
outside phagocytes. C. neoformans inside or outside phagocytes can be readily
distinguished by the negative or positive staining of Uvitex 2B. For each animal, 50
or more yeast cells were counted. The advantage of this method is that the in/out
status of C. neoformans will be instantly marked after Uvitex 2B injection; even if
the fungus later gets phagocytized, the staining at the time of Uvitex 2B treatment
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will remain. In some experiments, phagocytosis of C. neoformans was confirmed
using flow cytometry by distinguishing a double labeling of GFP and Uvitex 2B or a
single labeling of Uvitex 2B.
Growth assay. To compare the fungal growth in different organs, mice were i.v.
infected with 20 × 106 GFP-expressing C. neoformans or Uvitex 2B-labeled C.
albicans. The infected mice were euthanized at various time points post infection;
different organs were excised and immediately visualized under microscope. In
some experiments, mice were i.v. injected with 200 µl of CLL or PBS liposomes as
control to deplete KCs 24 h before infection. The total number of yeast cells in each
colony (each cluster of fungi was considered to be one colony) were counted under
a microscope. A colony containing at least two yeast cells was defined as growing
into a cluster.
Elisa assay. The level of IFN-γ in the liver homogenate was determined using IFN-
γ Elisa Kit (BD Biosciences) following the manufacturer’s instructions. After
euthanasia, the liver was collected and homogenized in a 15 ml tube containing 2
ml cold PBS, the supernatant was collected for Elisa after centrifugation at 3000 × g
for 10 min.
Statistics. GraphPad 5.0 was used for all statistical analyses. For single compar-
isons, an unpaired two-sided Student’s t test was performed; for multiple com-
parisons, one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test
or two-way ANOVA was used. In both cases, a p value of <0.05 is considered
significant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The datasets generated during and/or analyzed during the current study are available
from the corresponding author on reasonable request. The source data underlying
Figs. 1c, 2c–i, 3b–g, 4c–e, g–i, 5b, d–g, 6b–d, f–j and 7a, b, d, f and Supplementary Figs. 1,
2b, 3, 4a, b, 5b–d, f, 7c and 8 are provided as a Source Data file.
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